Search for Clinical Trial Results

Sponsored By

Dysgerminoma - 4 Studies Found

Status Study
Completed Study Name: Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)
Condition: Dysgerminoma
Date: 2005-09-13
Interventions: Drug: Darbepoetin alfa
Completed Study Name: Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
Condition:
  • Germ Cell Tumor
  • Nonseminomatous Germ Cell Tumor
  • Seminoma Date: 2017-05-16
    Interventions:
    • Drug: Durvalumab 1500 mg by IV
Terminated Study Name: Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer
Condition:
  • Ovarian Dysgerminoma
  • Recurrent Malignant Testicular Germ Cell T
    Date: 2002-08-05
    Interventions:
    • Drug: imatinib mesylate Given

Completed Study Name: Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
Condition:
  • Bladder Cancer
  • Brain and Central Nervous System Tumors
  • Bre
    Date: 2006-04-11
    Interventions:
    • Drug: lapatinib Other Names: